Takeaways

#
  • Lund had bought Meta after watching it recover toward its earnings gap and build a base.
  • He looked to the base and gap for evidence that the trade was working or breaking down.
  • Pfizer was a possible longer-term reversal, with its 200-day exponential moving average central to his chart.
  • Lund used fundamentals to find candidates but wanted price action to support the investment story.

Brian Lund had bought Meta in the previous evening’s after-hours session. What attracted him was the recovery after its earnings-related drop: buyers had brought the stock back toward the gap, where it was building a base.

Lund discussed the purchase with JC Parets, Steve Strazza and Spencer Israel on the June 5, 2024 Morning Show. He distinguished trading an earnings announcement from trading the price action that developed afterward. The latter was an approach he liked.

Meta’s recovery gave him a setup to manage

Lund described Meta falling sharply after earnings, then producing a green bar and working its way back toward the gap. He interpreted that recovery as evidence of buyers’ confidence in the company’s longer-term outlook.

The base beneath the gap mattered because it gave him a structure against which to manage the position. A breakdown would challenge the trade. A move above the gap level, he thought, could bring in new buyers and force short sellers to cover.

Parets added a comparison with the communications sector. Meta was holding above its previous cycle’s highs while the communications index remained below its own. He viewed that difference as a reason to favor Meta’s strength over waiting for the broader group to catch up.

Pfizer was a possible reversal

Lund was also watching Pfizer as a potential longer-term idea. He described a breakout from a roughly six-month base, followed by a test of the 200-day moving average, a pullback and another test.

He specified that he used an exponential moving average. Someone looking at a simple moving average could therefore see a different relationship between price and the 200-day line.

For Lund, the chart suggested that Pfizer might be finishing its basing stage.

Earlier in the interview, Lund recalled a persuasive cannabis-stock presentation from 2018 and the subsequent weakness in those stocks. He took it as a reminder that an investment story needed support from price action. Fundamentals could help him find candidates; the chart still had to justify his interest.

Questions and answers

#

Questions answered in the original 2024-06-05 episode.

What attracted Lund to Meta after earnings?

The stock had recovered toward its earnings gap and was building a base beneath it. He saw buyers returning and a chart structure he could use to manage the position.

Link to this answer

Which moving average did he use for Pfizer?

He used the 200-day exponential moving average. He noted that a chart using the simple moving average might look different.

Link to this answer

How did he use fundamental stories?

They could help him identify candidates, but he still wanted technical confirmation. He recalled the cannabis-stock boom as an example of a persuasive story that failed to hold up in the charts.

Link to this answer

Adapted by Stock Market TV Editorial from the original video. Source date: . Article published: .